sur DBV TECHNOLOGIES (EPA:DBV)
DBV Technologies publishes its 2026 Half-Year Financial Report
On July 16, 2026, DBV Technologies announced the publication of its 2026 Half-Year Financial Report. This report has been filed with the French Financial Markets Authority (AMF). The biotechnology company offers the opportunity to view or download this document on its website as well as on the AMF website.
DBV Technologies operates primarily in the food allergy treatment sector. It develops innovative solutions using its proprietary VIASKIN® patch technology. The company is listed on Euronext Paris and Nasdaq. Its headquarters are located in Châtillon, France, with operations in North America. For more information, please visit its online platforms.
R. H.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de DBV TECHNOLOGIES